27 SeptStarts in 1 day, 16 hours, 12 minutes and 34 secondsGlobal Tax & Compliance Search: Early AccessJoin early access →

PreciseDx

GRCHealthcare

Innovating oncology diagnostics through the power of AI. PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.

2019
Founded
7y
Age
$32M
Total funding
Healthcare
Area

Funding timeline

Aug 2024
Series B - PreciseDx
Jan 2022
Series A - PreciseDx
Members only

1 earlier round amount is shown to members.

Create a free account

Ask our AI about PreciseDx

A profile says who they are. Ask what it means: market size, ARR estimated from headcount, number of competitors, and implied runway and burn. Answered with sources.

Start researching